Family office deal-making rebounds in April with healthcare bets
CNBC • • general
Key Points:
- Investment firms managing ultra-wealthy family wealth increased their deal-making in April, making 55 direct investments compared to 39 in March, rebounding after a slowdown due to the Iran war outbreak.
- Nearly one-third of April's investments targeted healthcare and life sciences, reflecting a strong focus on these sectors among family offices.
- Laurene Powell Jobs' Emerson Collective participated in funding rounds for Ultralight, an AI healthcare platform, and Stipple Bio, a cancer therapy developer, with investments influenced by personal connections to healthcare challenges.
- Dolby Family Ventures invested in Exciva, a company developing treatments for agitation in Alzheimer's patients, motivated by founder David Dolby's personal experience with his father's illness.
- Family offices view healthcare innovation as a top investment theme, second only to artificial intelligence, especially as federal funding for healthcare research faces proposed cuts, including a $5 billion reduction to the NIH budget.
